FDA Approved: CHANTIX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for CHANTIX (varenicline tartrate) from Pfizer, authorizing changes to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Smoking Cessation

Drugs mentioned

• CHANTIX (varenicline tartrate)

Snippet

SUPPL AP for CHANTIX (VARENICLINE TARTRATE)